SLAS Discovery Volume 33 showcases new innovations in drug discovery
From high-throughput TRIP13 inhibitors to tau aggregation blockers, researchers tackle pressing challenges in drug discovery
2025-06-26
(Press-News.org) Oak Brook, IL – Volume 33 of SLAS Discovery features one review, three original research articles and one entry in the upcoming Special Issue on Biomolecular Condensates as Targets for Drug Discovery.
Reviews
Antimicrobial resistance: Linking molecular mechanisms to public health impact
This review highlights how β-lactamases and efflux pumps, combined with mobile genetic elements, drive the rapid spread of multidrug-resistant (MDR) and extremely drug-resistant (XDR) pathogens, posing a serious threat to global health and agriculture.
Original Research
Advancing the development of TRIP13 inhibitors: A high-throughput screening approach
In this study, the researchers developed a high-throughput luminescence-based assay to screen for TRIP13 inhibitors, identifying anlotinib as a promising candidate. Their discovery presents a new approach for targeting TRIP13 in cancers that are resistant to therapy and deficient in retinoblastoma.
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
This research assesses the effectiveness of apoptosis-targeting drugs—alrizomadlin, pelcitoclax and dasminapant—in solid tumor spheroids, both alone and in combination with other therapies. The results emphasize the potential of modifying the apoptosis pathway to improve cancer treatment in various aggressive solid tumors.
The authors identify small-molecule inhibitors of hyperphosphorylated tau aggregation and neurotoxicity through a high-throughput screen, offering a promising new therapeutic strategy for Alzheimer’s disease and related tauopathies by directly targeting tau pathology.
Biomolecular Condensates as Targets for Drug Discovery
This upcoming Special Issue, guest edited by Charles P. Hart, PhD (University of California, San Francisco), will explore the role of biomolecular condensates in diseases and the potential for drug discovery by modulating their formation, stability or dissolution in neurodegenerative, cancer and inflammatory disorders.
A biochemical screening platform to target chromatin states using condensates as a tool
This study presents a novel drug discovery approach that targets dysfunctional chromatin states by leveraging their phase-separated condensate properties, enabling the identification of context-specific small-molecule modulators to reduce off-target effects and enhance therapeutic potential.
Access to this issue of SLAS Discovery is available at https://www.slas-discovery.org/issue/S2472-5552(25)X0004-6
*****
SLAS Discovery reports how scientists develop and use novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. The journal focuses on drug discovery sciences with a strong record of scientific rigor and impact, reporting on research that:
Enables and improves target validation
Evaluates current drug discovery technologies
Provides novel research tools
Incorporates research approaches that enhance depth of knowledge and drug discovery success
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS Discovery: Advancing the Science of Drug Discovery, 2024 Impact Factor 2.7. Editor-in-Chief Robert M. Campbell, Ph.D., Grove Biopharma, Inc., Chicago, IL (USA)
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-06-26
Embargoed for release: Thursday, June 26, 2025, 6:00 AM ET
Boston, MA—In the midst of a multi-state measles outbreak, a new poll by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation finds that most U.S. adults (79%) say parents should be required to have children vaccinated against preventable diseases like measles, mumps, and rubella to attend school. This includes a majority of adults across party lines—90% among Democrats and 68% among Republicans – as well as 66% of those who support the “Make America Great Again” (MAGA) movement. It also includes 72% of all parents. ...
2025-06-26
Artificial intelligence is considered to be computationally and energy-intensive – a challenge for the Internet of Things (IoT), where small, embedded sensors have to make do with limited computing power, little memory and small batteries. In the E-MINDS project, a research team from the COMET K1 centre Pro2Future, Graz University of Technology (TU Graz) and the University of St. Gallen has found ways to run AI locally and efficiently on the smallest devices – without having to rely on external computing power. For example, it has been possible to run specialised AI models on an ultra-wideband localisation device ...
2025-06-26
Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is currently recommended in current UK guidelines, finds a new study led by UCL (University College London) researchers.
The results of the CATALYST study, published in The Lancet, included data from four randomised trials with a total of 5,441 patients across the UK, Switzerland, Sweden and the United States, who had all experienced a recent stroke (between 2017-2024) due to a blocked artery and atrial ...
2025-06-26
A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could revolutionize how hospitals treat rare diseases, even in low-resource settings.
Rare diseases affect millions worldwide, yet the one-size-fits-all model of drug development leaves patients with few treatment options. Now a European research project called NANOSPRESSO aims to tip the balance in patients’ favor by boosting access to low-cost bespoke gene and RNA therapies.
The prototype NANOSPRESSO device combines two proven technologies—nucleic acid ...
2025-06-26
LMU researchers have demonstrated a possible mechanism for metabolic processes without cell membranes in water-filled pores.
Looking at life today, it is difficult to imagine how complex biological processes and structures could have developed from simple building blocks. All cellular processes and reactions appear to be closely interdependent and necessarily occur within a cell membrane. There is no known organism that deviates from this pattern. But how did it come about?
How does a cell membrane form without metabolism? Or conversely, how does metabolism arise without a cell ...
2025-06-26
An interdisciplinary team of experts in green chemistry, engineering and physics at Flinders University in Australia has developed a safer and more sustainable approach to extract and recover gold from ore and electronic waste.
Explained in the leading journal Nature Sustainability, the gold-extraction technique promises to reduce levels of toxic waste from mining and shows that high purity gold can be recovered from recycling valuable components in printed circuit boards in discarded computers.
The project team, led by Matthew Flinders Professor Justin Chalker, applied this integrated method for high-yield gold extraction ...
2025-06-26
Optical biosensors use light waves as a probe to detect molecules, and are essential for precise medical diagnostics, personalized medicine, and environmental monitoring. Their performance is dramatically enhanced if they can focus light waves down to the nanometer scale – small enough to detect proteins or amino acids, for example – using nanophotonic structures that ‘squeeze’ light at the surface of a tiny chip. But the generation and detection of light for these nanophotonic biosensors requires ...
2025-06-26
Scientists at the University of Oxford have unveiled a pioneering method for capturing the full structure of ultra-intense laser pulses in a single measurement.
The breakthrough, published in close collaboration with Ludwig-Maximilian University of Munich and the Max Planck Institute for Quantum Optics, could revolutionise our ability to control light-matter interactions.
This would have transformative applications in many areas, including research into new forms of physics and realising the extreme ...
2025-06-26
Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet in Sweden shows that some immune cells with high inflammatory potential are not completely eradicated after treatment.
Biological drugs (biologics) have become an important tool in the treatment of severe asthma.
“They help most patients to keep their symptoms under control, but exactly how these drugs affect the immune system has so far remained unknown,” says Valentyna Yasinska, consultant ...
2025-06-26
A new international study drawing on 73 million nights of data reveals that our sleep patterns are seriously shaped by the day of the week, the season, and where we live.
Working with sleep data from more than 116,000 adults across the globe, Flinders University sleep experts used insights from an FDA-cleared under-mattress device to track sleep duration and timing over 3.5 years.
Lead author, Dr Hannah Scott from FHMRI Sleep Health says the findings give a detailed look at how geography, seasons, and our day-to-day schedules quietly disrupt the way we sleep.
“Sleep patterns aren’t just about habits – they’re deeply connected to the environment around ...
LAST 30 PRESS RELEASES:
[Press-News.org] SLAS Discovery Volume 33 showcases new innovations in drug discovery
From high-throughput TRIP13 inhibitors to tau aggregation blockers, researchers tackle pressing challenges in drug discovery
